![Chris Boshoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Boshoff
Presidente presso
SEAGEN INC.
Patrimonio netto: 4 M $ in data 31/05/2026
Profilo
Chris Boshoff currently works at Pfizer Inc., as President-R&D & Chief Scientific Officer from 2025, Seagen, Inc., as President from 2023, and Pfizer (La Jolla), as Vice President-Translational Oncology.
Dr. Boshoff also formerly worked at Advanced Oncotherapy Plc, as Non-Executive Director in 2013 and UCL Cancer Institute Research Trust, as Founding Director.
Dr. Boshoff received his doctorate degree from Institute of Cancer Research Royal Marsden Hospital.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/03/2026 | 162.088 ( 0% ) | 4 M $ | 31/05/2026 |
Ultime notizie su Chris Boshoff
Posizioni attive di Chris Boshoff
| Società | Posizione | Inizio |
|---|---|---|
| PFIZER INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2025 |
| SEAGEN INC. | Presidente | 14/12/2023 |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Corporate Officer/Principal | - |
Precedenti posizioni note di Chris Boshoff
| Società | Posizione | Fine |
|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Direttore/Membro del Consiglio | 25/10/2013 |
UCL Cancer Institute Research Trust | Direttore/Membro del Consiglio | - |
Formazione di Chris Boshoff
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Advanced Oncotherapy Plc
 Advanced Oncotherapy Plc Medical SpecialtiesHealth Technology Develops and provides advanced cancer treatments | Health Technology |
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
UCL Cancer Institute Research Trust | |
Institute of Cancer Research Royal Marsden Hospital
 Institute of Cancer Research Royal Marsden Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
